- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Sequenom, Inc. (NASDAQ: SQNM) reported that its third quarter revenue was $9.2 million, declining by 20%, net loss of $14.9 million versus $10.4 million a year earlier partly due to higher expenses. However, the gross margin saw an increase to 71% from 61% same period last year.
Sequenom, Inc. reported total costs and expenses of $24.3 million for the third quarter as compared to $22.3 million a year earlier.
As a result, shares of Sequenom, Inc. have plunged 3.96% to $3.15 in the pre-market trading. Yesterday, the stock closed at $3.28.